Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
VANDA regimen followed by blinatumomab leads to favourable outcome in patients with Philadelphia chromosome-negative B-precursor acute lymphoblastic leukaemia in first relapse.
Heraudet L, Galtier J, Favre S, Peyraud F, Cazaubiel T, Leroy H, Mottal N, Gros FX, Forcade E, Clément L, Dumas PY, Pigneux A, Leguay T. Heraudet L, et al. Among authors: galtier j. Br J Haematol. 2022 Aug;198(3):523-527. doi: 10.1111/bjh.18218. Epub 2022 May 7. Br J Haematol. 2022. PMID: 35524489
Vinblastine for elderly and frail patients with Hodgkin lymphoma.
Meynard L, Galtier J, Favre S, Debus L, Lascaux A, Dilhuydy MS, Gros FX, Sauvezie M, Milpied N, Bouabdallah K, Dimicoli S. Meynard L, et al. Among authors: galtier j. Leuk Lymphoma. 2020 Dec;61(13):3239-3242. doi: 10.1080/10428194.2020.1797009. Epub 2020 Jul 27. Leuk Lymphoma. 2020. PMID: 32716269 No abstract available.
Delivering HDAC over 3 or 5 days as consolidation in AML impacts health care resource consumption but not outcome.
Dumas PY, Bertoli S, Bérard E, Leguay T, Tavitian S, Galtier J, Alric C, Bidet A, Delabesse E, Rieu JB, Vial JP, Vergez F, Lechevalier N, Luquet I, Klein E, Sarry A, Rey H, de Grande AC, Despas F, Pigneux A, Récher C. Dumas PY, et al. Among authors: galtier j. Blood Adv. 2020 Aug 25;4(16):3840-3849. doi: 10.1182/bloodadvances.2020002511. Blood Adv. 2020. PMID: 32790847 Free PMC article.
Intermediate-dose cytarabine or standard-dose cytarabine plus single-dose anthracycline as post-remission therapy in older patients with acute myeloid leukemia: impact on health care resource consumption and outcomes.
Galtier J, Alric C, Bérard E, Leguay T, Tavitian S, Bidet A, Delabesse E, Rieu JB, Vial JP, Vergez F, Lechevalier N, Luquet I, Klein E, de Grande AC, Sarry A, Pigneux A, Récher C, Bertoli S, Dumas PY. Galtier J, et al. Blood Cancer J. 2021 Nov 13;11(11):180. doi: 10.1038/s41408-021-00551-y. Blood Cancer J. 2021. PMID: 34775463 Free PMC article. No abstract available.
Positron emission tomography-imaging assessment for guiding strategy in patients with relapsed/refractory large B-cell lymphoma receiving CAR T cells.
Galtier J, Vercellino L, Chartier L, Olivier P, Tabouret-Viaud C, Mesguich C, Di Blasi R, Durand A, Raffy L, Gros FX, Madelaine I, Meignin V, Mebarki M, Rubio MT, Feugier P, Casasnovas O, Meignan M, Thieblemont C. Galtier J, et al. Haematologica. 2023 Jan 1;108(1):171-180. doi: 10.3324/haematol.2021.280550. Haematologica. 2023. PMID: 35678029 Free PMC article.
First clinical description of a pedigree with complete NAF1 deletion.
Galtier J, Dimicoli-Salazar S, Trimouille A, Lainey E, Revy P, Bidet A, Vial Y, Forcade E, Negrier-Leibreich ML, Rivière E, Tinat J, Le Meur N, Ménard C, Pigneux A, Leguay T, Dumas PY, Ibrahima B, Kannengiesser C. Galtier J, et al. Leuk Lymphoma. 2023 Feb;64(2):487-490. doi: 10.1080/10428194.2022.2148377. Epub 2022 Nov 23. Leuk Lymphoma. 2023. PMID: 36416722 No abstract available.
Late relapse after hematopoietic stem cell transplantation for acute leukemia: a retrospective study by SFGM-TC.
Kaphan E, Bettega F, Forcade E, Labussière-Wallet H, Fegueux N, Robin M, Peffault De Latour R, Huynh A, Lapierre L, Berceanu A, Marcais A, Debureaux PE, Vanlangendonck N, Bulabois CE, Magro L, Daniel A, Galtier J, Lioure B, Chevallier P, Antier C, Loschi M, Guillerm G, Mear JB, Chantepie S, Cornillon J, Rey G, Poire X, Bazarbachi A, Rubio MT, Contentin N, Orvain C, Dulery R, Bay JO, Croizier C, Beguin Y, Charbonnier A, Skrzypczak C, Desmier D, Villate A, Carré M, Thiebaut-Bertrand A. Kaphan E, et al. Among authors: galtier j. Transplant Cell Ther. 2023 Jun;29(6):362.e1-362.e12. doi: 10.1016/j.jtct.2023.02.020. Epub 2023 Feb 26. Transplant Cell Ther. 2023. PMID: 36849078 Free article.
Combined Reverse-Transcriptase Multiplex Ligation-Dependent Probe Amplification and Next-Generation Sequencing Analyses to Assign Unclassified BCL2-/BCL6- Nonrearranged Small B-Cell Lymphoid Neoplasms as Follicular or Nodal Marginal Zone Lymphoma.
Sesboue C, Galtier J, Jeanneau M, Chauvel A, Laharanne E, Amintas S, Merlio JP, Bouabdallah K, Gros FX, de Leval L, Gros A, Parrens M. Sesboue C, et al. Among authors: galtier j. Mod Pathol. 2023 Feb;36(2):100043. doi: 10.1016/j.modpat.2022.100043. Epub 2023 Jan 10. Mod Pathol. 2023. PMID: 36853790 Free article.
Cost comparison of post-remission strategies in younger and older AML patients in France.
Mounie M, Dumas PY, Liva-Yonnet S, Fabre D, Leguay T, Galtier J, Berard E, Hanta R, Gilleron V, Bertoli S, Pigneux A, Récher C, Costa N. Mounie M, et al. Among authors: galtier j. Blood Cancer J. 2023 Jun 28;13(1):100. doi: 10.1038/s41408-023-00874-y. Blood Cancer J. 2023. PMID: 37380651 Free PMC article. No abstract available.
43 results